These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35364706)
1. A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report. Xu X; Wang H; Yu Z; Chen X J Cancer Res Clin Oncol; 2022 Jul; 148(7):1825-1827. PubMed ID: 35364706 [TBL] [Abstract][Full Text] [Related]
2. Identifification of a novel LDLR-RET Fusion in Lung Adenocarcinoma. Shi G; Luo Y; Yu Z; Wang Y; Zhu B Invest New Drugs; 2022 Aug; 40(4):858-860. PubMed ID: 35524867 [TBL] [Abstract][Full Text] [Related]
3. The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients. Wu G; Guo L; Gu Y; Huang T; Liu M; Zou X; Yang B; Huang P; Wen C; Yi L; Liao W; Zhao D; Zhu J; Zhang X; Liu Y; Yin Y; Chen S J Cancer Res Clin Oncol; 2023 Mar; 149(3):1019-1028. PubMed ID: 35220468 [TBL] [Abstract][Full Text] [Related]
4. A novel PIBF1-RET gene fusion identified from a stage IA lung adenocarcinoma: A case report. Zhao W; Sun J; Zhu H; Zhao G Medicine (Baltimore); 2023 Jul; 102(29):e34305. PubMed ID: 37478265 [TBL] [Abstract][Full Text] [Related]
5. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. Wang R; Hu H; Pan Y; Li Y; Ye T; Li C; Luo X; Wang L; Li H; Zhang Y; Li F; Lu Y; Lu Q; Xu J; Garfield D; Shen L; Ji H; Pao W; Sun Y; Chen H J Clin Oncol; 2012 Dec; 30(35):4352-9. PubMed ID: 23150706 [TBL] [Abstract][Full Text] [Related]
6. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. Lira ME; Choi YL; Lim SM; Deng S; Huang D; Ozeck M; Han J; Jeong JY; Shim HS; Cho BC; Kim J; Ahn MJ; Mao M J Mol Diagn; 2014 Mar; 16(2):229-43. PubMed ID: 24418728 [TBL] [Abstract][Full Text] [Related]
8. Novel targets in non-small cell lung cancer: ROS1 and RET fusions. Gainor JF; Shaw AT Oncologist; 2013; 18(7):865-75. PubMed ID: 23814043 [TBL] [Abstract][Full Text] [Related]
9. RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis. Tsuta K; Kohno T; Yoshida A; Shimada Y; Asamura H; Furuta K; Kushima R Br J Cancer; 2014 Mar; 110(6):1571-8. PubMed ID: 24504365 [TBL] [Abstract][Full Text] [Related]
10. Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer. Li W; Wan R; Guo L; Chang G; Jiang D; Meng L; Ying J BMC Med; 2022 May; 20(1):160. PubMed ID: 35534835 [TBL] [Abstract][Full Text] [Related]
11. RET fusion genes in Korean non-small cell lung cancer. Yoo SS; Jin G; Jung HJ; Hong MJ; Choi JE; Jeon HS; Lee SY; Lim JO; Park JY J Korean Med Sci; 2013 Oct; 28(10):1555-8. PubMed ID: 24133367 [TBL] [Abstract][Full Text] [Related]
12. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Lipson D; Capelletti M; Yelensky R; Otto G; Parker A; Jarosz M; Curran JA; Balasubramanian S; Bloom T; Brennan KW; Donahue A; Downing SR; Frampton GM; Garcia L; Juhn F; Mitchell KC; White E; White J; Zwirko Z; Peretz T; Nechushtan H; Soussan-Gutman L; Kim J; Sasaki H; Kim HR; Park SI; Ercan D; Sheehan CE; Ross JS; Cronin MT; Jänne PA; Stephens PJ Nat Med; 2012 Feb; 18(3):382-4. PubMed ID: 22327622 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. Sun F; McCoach CE Curr Treat Options Oncol; 2021 Jun; 22(8):72. PubMed ID: 34165651 [TBL] [Abstract][Full Text] [Related]
14. The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis. Lin C; Wang S; Xie W; Chang J; Gan Y Cancer Biol Ther; 2015; 16(7):1019-28. PubMed ID: 25975578 [TBL] [Abstract][Full Text] [Related]
15. KIF5B-RET fusions in Chinese patients with non-small cell lung cancer. Cai W; Su C; Li X; Fan L; Zheng L; Fei K; Zhou C Cancer; 2013 Apr; 119(8):1486-94. PubMed ID: 23378251 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small Cell Lung Cancer in China. Lu S; Shen L; Wang Q; Chen H; Zhao Y; Li Y; Segall G; Khanal M; Zhang X; Ding D; Shao J; Pang L Adv Ther; 2024 Nov; 41(11):4248-4265. PubMed ID: 39316291 [TBL] [Abstract][Full Text] [Related]
17. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers. Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819 [TBL] [Abstract][Full Text] [Related]
19. Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC. Li W; Liu Y; Li W; Chen L; Ying J J Thorac Oncol; 2020 Jul; 15(7):1223-1231. PubMed ID: 32151779 [TBL] [Abstract][Full Text] [Related]
20. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Ju YS; Lee WC; Shin JY; Lee S; Bleazard T; Won JK; Kim YT; Kim JI; Kang JH; Seo JS Genome Res; 2012 Mar; 22(3):436-45. PubMed ID: 22194472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]